The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea

BACKGROUND: In Papua New Guinea (PNG), combination therapy with amodiaquine (AQ) or chloroquine (CQ) plus sulphadoxine-pyrimethamine (SP) was introduced as first-line treatment against uncomplicated malaria in 2000. METHODS: We assessed in vivo treatment failure rates with AQ+SP in two different are...

Descripción completa

Detalles Bibliográficos
Autores principales: Marfurt, Jutta, Müller, Ivo, Sie, Albert, Oa, Olive, Reeder, John C, Smith, Thomas A, Beck, Hans-Peter, Genton, Blaise
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377269/
https://www.ncbi.nlm.nih.gov/pubmed/18423045
http://dx.doi.org/10.1186/1475-2875-7-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377269/
https://www.ncbi.nlm.nih.gov/pubmed/18423045
http://dx.doi.org/10.1186/1475-2875-7-61

Ejemplares similares